MDWD MediWound Ltd. - Ordinary Shares
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 5, 2026
$13.52
· of 52w range
· above low
· to high
$12.5252w low
$20.0352w high
P/E
-8.8
EPS
$-2.10
Revenue
$17M
your badges
52W Range
$13–$20
Analyst Rating
BUY
Price Target
$31
P/E
-8.8
ROE
-63.9%
Net Profit Margin
-140.8%
Your badge strip is empty — pin a metric anywhere on this page.
MDWD Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$13.52
P/E
-8.8
EPS
$-2.10
Revenue
$17M
ROE
-63.9%
52W Range
$13–$20
MDWD Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Dec. 20, 2022 | 1-for-7 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$17M2016-12-31 → 2025-12-31
EPS$-2.102020-12-31 → 2025-12-31
Free Cash Flow$-22M2017-12-31 → 2025-12-31
Net margin-140.8%2017-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | MDWD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -8.85Y avg ≈-7.3 | ≈-7.3 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | MDWD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 19.2%5Y avg ≈27.6% | ≈27.6% | · | · | |
| Operating Margin | -149.0%5Y avg ≈-81.1% | ≈-81.1% | · | · | |
| EBITDA Margin | -145.5%5Y avg ≈-78.2% | ≈-78.2% | · | · | |
| Pretax Margin | -139.8%5Y avg ≈-90.9% | ≈-90.9% | · | · | |
| Net Profit Margin | -140.8%5Y avg ≈-91.4% | ≈-91.4% | · | · | |
| ROA | -29.9%5Y avg ≈-38.8% | ≈-38.8% | · | · | |
| ROE | -63.9%5Y avg ≈-363.7% | ≈-363.7% | · | · | |
| ROIC | -58.3%5Y avg ≈-0.37% | ≈-0.37% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | MDWD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 2.35Y avg ≈2.8 | ≈2.8 | · | · | |
| Quick Ratio | 0.25Y avg ≈1.1 | ≈1.1 | · | · | |
| Interest Coverage | -10.35Y avg ≈-5.1 | ≈-5.1 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | MDWD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.25Y avg ≈0.5 | ≈0.5 | · | · | |
| Inventory Turnover | 4.05Y avg ≈7.3 | ≈7.3 | · | · | |
| Revenue / Employee | ≈$140.2K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
25.8%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 13, 2026 | $-0.57 | $-0.78 | 26.6% |
| March 31, 2026 | May 27, 2026 | $-0.23 | $-0.67 | 65.6% |
| Dec. 31, 2025 | $-0.56 | $-0.64 | 13.1% | |
| Sept. 30, 2025 | $-0.24 | $-0.83 | 71.0% | |
| June 30, 2025 | $-1.23 | $-0.58 | -110.9% | |
| March 31, 2025 | $-0.07 | $-0.67 | 89.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17M | $20M | $19M | $26M | $24M | $22M | $32M | $3M | $2M | $2M | |
| Cost of Revenue | $14M | $18M | $15M | $13M | $15M | $14M | $12M | $2M | $2M | $2M | |
| Gross Profit | $3M | $3M | $4M | $13M | $9M | $8M | $20M | $1M | $918.0K | $-600.0K | |
| R&D Expense | $14M | $9M | $7M | $10M | $10M | $8M | $5M | $4M | $5M | $7M | |
| SG&A Expense | $8M | $8M | $7M | $7M | $6M | $5M | $5M | $4M | $4M | $4M | |
| Operating Income | $-25M | $-19M | $-15M | $-8M | $-11M | $-9M | $4M | $-4M | $-14M | $-20M | |
| Interest Expense | $2M | $13M | $2M | $12M | $2M | $1M | $3M | $2M | $1M | $896.0K | |
| Interest Income | $4M | $2M | $11M | $461.0K | $11.0K | $843.0K | $556.0K | $412.0K | $406.0K | $2M | |
| Pretax Income | $-24M | $-30M | $-7M | $-20M | $-14M | $-9M | $2M | · | · | · | |
| Income Tax | $169.0K | $61.0K | $185.0K | $78.0K | $27.0K | $0 | $0 | · | · | · | |
| Net Income | $-24M | $-30M | $-7M | $-20M | $-14M | $-9M | $5M | $-1M | $-22M | $-19M | |
| EPS (Basic) | $-2.10 | $-3.03 | $-0.75 | $-3.93 | $-3.48 | $-2.38 | · | · | · | · | |
| EPS (Diluted) | $-2.10 | $-3.03 | $-0.75 | $-3.93 | $-3.48 | $-2.38 | · | · | · | · | |
| Shares (Basic) | 11,376,571 | 9,959,723 | 9,013,144 | 4,987,069 | 3,892,068 | · | · | 27,113,617 | 23,341,040 | 21,862,169 | |
| Shares (Diluted) | 11,376,571 | 9,959,723 | 9,013,144 | 4,987,069 | 3,892,068 | 27,209,878 | 27,178,839 | 27,113,617 | 23,341,040 | · | |
| EBITDA | $-25M | $-19M | $-15M | $-8M | $-11M | $-8M | $5M | $-3M | $-13M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $9M | $12M | $34M | $11M | $17M | $7M | $7M | $36M | $29M | |
| Inventory | $4M | $3M | $3M | $2M | $1M | $1M | $2M | $2M | $2M | $844.0K | |
| Current Assets | $60M | $52M | $50M | $46M | $15M | $26M | $36M | $33M | $42M | $34M | |
| PP&E (Net) | $19M | $14M | $9M | $2M | $2M | $3M | $2M | $2M | $2M | $1M | |
| Intangibles | $33.0K | $99.0K | $165.0K | $231.0K | $297.0K | $363.0K | $429.0K | $495.0K | $635.0K | $773.0K | |
| Total Assets | $86M | $73M | $66M | $50M | $20M | $31M | $41M | $35M | $44M | $36M | |
| Accounts Payable | $8M | $5M | $6M | · | · | · | · | · | · | · | |
| Current Liabilities | $26M | $27M | $18M | $12M | $11M | $8M | $10M | $5M | $5M | $5M | |
| Total Liabilities | $43M | $42M | $35M | $39M | $24M | $24M | · | · | · | · | |
| Retained Earnings | $-229M | $-205M | $-175M | $-168M | $-149M | $-135M | $-126M | $-131M | $-129M | $-107M | |
| Stockholders' Equity | $44M | $31M | $32M | $11M | $-5M | $7M | $15M | $9M | $9M | $8M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $591.0K | $630.0K | $672.0K | $426.0K | $559.0K | $387.0K | $512.0K | $474.0K | $457.0K | $475.0K | |
| Other Non-cash | $7M | $16M | $-4M | $7M | $4M | $2M | $3M | $-12M | $5M | · | |
| Operating Cash Flow | $-16M | $-14M | $-10M | $-12M | $-9M | $-7M | $8M | $-12M | $-16M | $-16M | |
| CapEx | $6M | $6M | $6M | $555.0K | $489.0K | $923.0K | $792.0K | $522.0K | $1M | $671.0K | |
| Investing Cash Flow | $-18M | $-8M | $-34M | $-481.0K | $4M | $17M | $-7M | $-17M | $437.0K | $2M | |
| Financing Cash Flow | $30M | $19M | $23M | $36M | $-1M | · | · | $46.0K | $23M | $907.0K | |
| Free Cash Flow | $-22M | $-20M | $-17M | $-12M | $-9M | $-8M | $7M | $-13M | $-18M | · | |
| Levered FCF | $-24M | $-33M | $-19M | $-24M | $-12M | · | · | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 19.2% | 13.0% | 19.1% | 49.7% | 36.9% | 34.7% | 62.7% | 38.6% | 36.8% | · | |
| Operating Margin | -149.0% | -95.9% | -81.8% | -31.5% | -47.2% | -40.6% | 14.1% | -116.4% | -548.4% | · | |
| Net Margin | -140.8% | -149.5% | -35.9% | -74.0% | -57.0% | -42.3% | 15.6% | -31.1% | -887.4% | · | |
| Pretax Margin | -139.8% | -149.2% | -34.9% | -73.7% | -56.9% | · | · | · | · | · | |
| EBITDA Margin | -145.5% | -92.8% | -78.2% | -29.9% | -44.7% | -38.1% | 15.7% | -102.5% | -530.1% | · | |
| ROA | -29.9% | -43.2% | -11.5% | -56.2% | -53.3% | -25.7% | 13.1% | -2.7% | -55.4% | · | |
| ROE | -63.9% | -96.3% | -31.6% | -619.0% | -1007.5% | -82.0% | 41.0% | -11.5% | -254.7% | · | |
| ROIC | -58.3% | -62.4% | -49.8% | -76.8% | 245.4% | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.0 | 4.6 | 3.8 | 1.4 | 3.2 | 3.4 | 6.7 | 7.6 | · | |
| Quick Ratio | 0.2 | 0.3 | 1.1 | 2.8 | 1.0 | 2.1 | 0.7 | 1.4 | 6.6 | · | |
| Interest Coverage | -10.3 | -1.5 | -8.1 | -0.7 | -4.8 | -6.9 | 1.5 | -1.9 | -10.9 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.3 | 0.3 | 0.8 | 0.9 | 0.6 | 0.8 | 0.1 | 0.1 | · | |
| Inventory Turnover | 4.0 | 6.4 | 6.3 | 8.4 | 11.6 | 9.5 | 7.2 | 1.2 | 1.2 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $1.49 | $2.03 | $2.07 | · | · | $0.80 | $1.17 | $0.13 | $0.11 | · | |
| Cash Flow / Share | $-1.42 | $-1.37 | $-1.16 | · | · | $-0.25 | $0.30 | $-0.45 | $-0.70 | · | |
| EPS (TTM) | $-2.10 | $-3.03 | $-0.75 | $-3.93 | $-3.48 | $-2.38 | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17M | $20M | $19M | $26M | $24M | $22M | $32M | $3M | $2M | · | |
| Net Income TTM | $-24M | $-30M | $-7M | $-20M | $-14M | $-9M | $5M | $-1M | $-22M | · | |
| P/E | -8.8 | -5.9 | -13.6 | -3.4 | -4.7 | -10.9 | · | · | · | · | |
| Earnings Yield | -11.4% | -17.0% | -7.4% | -29.1% | -21.1% | -9.2% | · | · | · | · |
Valuation (TTM)
| Metric | Trend | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue TTM | $2M | $601.0K | · | |
| Net Income TTM | $-19M | $-22M | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $17M | $20M | $19M | $26M | $24M |
| Gross Margin % | 19.2% | 13.0% | 19.1% | 49.7% | 36.9% |
| Operating Margin % | -149.0% | -95.9% | -81.8% | -31.5% | -47.2% |
| Net Income | $-24M | $-30M | $-7M | $-20M | $-14M |
| Diluted EPS | $-2.10 | $-3.03 | $-0.75 | $-3.93 | $-3.48 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.0 | 4.6 | 3.8 | 1.4 |
| Quick Ratio | 0.2 | 0.3 | 1.1 | 2.8 | 1.0 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-22M | $-20M | $-17M | $-12M | $-9M |
Institutional owners (13F) 88 filers · $83.3M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
88
Value held
$83.3M
New positions
15
Exited positions
11
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 15 (-3 vs prior Q) | 11 (-5 vs prior Q) | 29 (+1 vs prior Q) | 20 (+2 vs prior Q) | -249K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| INVESTOR AB | $12,819,767 | 872,093 | 15.39% | Shares |
| Yelin Lapidot Holdings Management Ltd. | $11,145,085 | 758,169 | 13.38% | Shares |
| Rosalind Advisors, Inc. | $11,011,094 | 749,054 | 13.22% | Shares |
| BlackRock, Inc. | $7,731,157 | 525,929 | 9.28% | Shares |
| KOTLER KEVIN | $6,225,377 | 337,236 | 7.47% | Shares |
| SPHERA FUNDS MANAGEMENT LTD. | $4,015,922 | 273,192 | 4.82% | Shares |
| Silverberg Bernstein Capital Management LLC | $3,353,614 | 228,137 | 4.03% | Shares |
| STATE STREET CORP | $2,479,434 | 168,669 | 2.98% | Shares |
| UBS Group AG | $2,292,054 | 155,922 | 2.75% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $2,073,302 | 141,041 | 2.49% | Shares |
| Point72 Asset Management, L.P. | $1,899,946 | 129,248 | 2.28% | Shares |
| ARK Investment Management LLC | $1,860,667 | 126,576 | 2.23% | Shares |
| NORTHERN TRUST CORP | $1,649,208 | 112,191 | 1.98% | Shares |
| DAFNA Capital Management LLC | $1,387,754 | 94,405 | 1.67% | Shares |
| MORGAN STANLEY | $1,303,303 | 88,660 | 1.56% | Shares |
| VANGUARD GROUP INC | $1,205,364 | 65,296 | 1.45% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,031,102 | 70,143 | 1.24% | Shares |
| Sargent Investment Group, LLC | $918,471 | 62,481 | 1.10% | Shares |
| CITADEL ADVISORS LLC | $859,891 | 58,496 | 1.03% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $740,250 | 50,357 | 0.89% | Shares |
| Summit Financial, LLC | $689,628 | 46,914 | 0.83% | Shares |
| Phoenix Financial Ltd. | $572,905 | 39,000 | 0.69% | Shares |
| LPL Financial LLC | $519,454 | 35,337 | 0.62% | Shares |
| GOLDMAN SACHS GROUP INC | $493,214 | 33,552 | 0.59% | Shares |
| Sheets Smith Investment Management | $362,022 | 20,090 | 0.43% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $356,769 | 24,270 | 0.43% | Shares |
| MGO ONE SEVEN LLC | $325,737 | 22,159 | 0.39% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $289,149 | 19,670 | 0.35% | Shares |
| Bank of New York Mellon Corp | $272,979 | 18,570 | 0.33% | Shares |
| PVG ASSET MANAGEMENT CORP | $266,393 | 18,122 | 0.32% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $253,943 | 17,275 | 0.30% | Shares |
| WELLS FARGO & COMPANY/MN | $243,560 | 16,569 | 0.29% | Shares |
| OPPENHEIMER & CO INC | $235,391 | 16,013 | 0.28% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $220,500 | 15,000 | 0.26% | Put option |
| J. Goldman & Co LP | $192,129 | 13,070 | 0.23% | Shares |
| Invesco Ltd. | $189,057 | 12,861 | 0.23% | Shares |
| RHUMBLINE ADVISERS | $178,275 | 12,128 | 0.21% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $176,400 | 12,000 | 0.21% | Call option |
| Nuveen, LLC | $158,745 | 10,799 | 0.19% | Shares |
| Thomasville National Bank | $154,350 | 10,500 | 0.19% | Shares |
| Y.D. More Investments Ltd | $152,880 | 10,400 | 0.18% | Shares |
| DEUTSCHE BANK AG\ | $147,544 | 10,037 | 0.18% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $137,960 | 9,385 | 0.17% | Shares |
| Russell Investments Group, Ltd. | $99,401 | 6,762 | 0.12% | Shares |
| FMR LLC | $75,764 | 5,154 | 0.09% | Shares |
| CITIGROUP INC | $70,487 | 4,795 | 0.08% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $69,193 | 4,707 | 0.08% | Shares |
| JPMORGAN CHASE & CO | $63,894 | 4,237 | 0.08% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $51,450 | 3,500 | 0.06% | Shares |
| Pinnacle Wealth Planning Services, Inc. | $30,988 | 2,108 | 0.04% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Access Industries Holdings LLC, Access Industries, LLC, Access Industries Management, LLC, Clal Industries Ltd., Clal Biotechnology Industries Ltd., Clal Life Sciences L.P., Len Blavatnik ×7 filings | Oct. 3, 2025 | 11.56% | Amendment | · | SEC |
| Mölnlycke Health Care AB, MHC Sweden AB, Mölnlycke Holding AB, Mölnlycke AB, Rotca AB, Patricia Industries AB, Investor AB | July 19, 2024 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 4 insiders · 1 officers · 3 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Shmuel Hess | COO & Chief Commercial Officer | Aug. 27, 2026 M | 0 | 0 | 3 | $-75,402 |
| Samuel Rubinstein | Director | Sept. 1, 2026 P | 525 | 2 | 1 | $2,098 |
| Nachum Shamir | Director | June 3, 2026 P | 55,815 | 2 | 0 | $83,996 |
| David Morton Fox | Director | June 1, 2026 P | 22,283 | 3 | 0 | $49,901 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 10 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.56% | 9,514 SH | Oct. 2, 2026 | Daily |
| IWC · iShares Trust | 0.03% | 33,943 SH | Sept. 10, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 10,425 SH | Aug. 19, 2026 | Daily |
| IWO · iShares Trust | 0.01% | 91,113 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.00% | 4,895 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.00% | 236,233 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 13,396 SH | Sept. 3, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 58,533 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 575 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 610 SH | Aug. 19, 2026 | Daily |
MDWD Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 12 analysts
BUY
Median target
$30.00
+121.9%
3 25.0%
Strong Buy
8 66.7%
Buy
1 8.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
6 analysts · 2026-10-03Mean target $30.67 +126.8%
← Below all targets
Current price $13.52
Low$25.00
Mean$30.67
High$36.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Mar 5, 2026